Overview * Sana Biotechnology ( SANA ) Q3 net loss of $42.2 mln, with operating expenses of $43.5 mln * Raised $115.8 mln from stock sales, cash position at $153.1 mln * Company prioritizes SC451 and SG293, suspends other CAR T programs Result Drivers * TYPE 1 DIABETES FOCUS - Sana prioritizes SC451 development due to promising clinical results and...

05:07 PM EST, 11/06/2025 (MT Newswires) -- Richard D Fairbank, Director, Chairman and CEO, on November 04, 2025, sold 103,487 shares in Capital One Financial ( COF ) for $22,837,982. Following the Form 4 filing with the SEC, Fairbank has control over a total of 4,001,228 common shares of the company, with 4,001,228 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/927628/000123803225000008/xslF345X05/wk-form4_1762466621.xml ...

05:07 PM EST, 11/06/2025 (MT Newswires) -- Steven M. Quirk, Chief Brokerage Officer, on November 04, 2025, sold 48,350 shares in Robinhood Markets ( HOOD ) for $6,798,677. Following the Form 4 filing with the SEC, Quirk has control over a total of 70,279 Class A common shares of the company, with 70,279 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783879/000178387925000312/xslF345X05/wk-form4_1762466506.xml ...

05:07 PM EST, 11/06/2025 (MT Newswires) -- Michael Chase, Executive Vice President and Chief Investment Officer, on November 05, 2025, sold 13,144 shares in Stag Industrial ( STAG ) for $509,304. Following the Form 4 filing with the SEC, Chase has control over a total of 9,422 common shares of the company, with 9,422 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1479094/000193704625000005/xslF345X05/form4-11062025_091115.xml...